Drotaverine
Drotaverine is a pharmaceutical drug with 3 clinical trials. Historical success rate of 50.0%.
Registry-listed formulations
Drotaverine · chembl:CHEMBL551978
Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.
1 source entries across 1 studies. This list may not include all unresolved or historical entries.
- DrotaverineRegistry intervention
Molecular identity unconfirmed
View study and source
Success Metrics
Based on 1 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
2
Mid Stage
1
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
50.0%
1 of 2 finished
50.0%
1 ended early
0
trials recruiting
3
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Clinical Trials (3)
Drotaverine in Dysmenorrhoea Treatment
Drotaverine to Shorten the Length of Labor
Meperidine Versus Drotaverine Regarding the Effect on the Duration of the First Stage of Labor in Full Term Primigravidae
All 3 trials loaded
Drug Details
- Intervention Type
- Drug
- Molecule Type
- Small molecule
- Total Trials
- 3